Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A generous gift from The Sir John Ritblat Family Foundation has enabled the creation of a new Professorship in Mindfulness and Psychological Science.

A MINDFULNESS-BASED COGNITIVE THERAPY TRAINING SESSION LED BY WILLEM KUYKEN AND MARK WILLIAMS (SHANGHAI, 2018)

The post, which is to be held by the Director of the Oxford Mindfulness Centre, promises to transform our understanding of the link between mind and body, and lead the world into a new era of human health.

Sometimes described as 'the art of conscious living', mindfulness is a natural capacity for moment-by-moment awareness – a practice that enables us to change the way we think and feel about our experiences by developing attentiveness to the present. In recent years, mindfulness has become a recognised form of treatment for both physical and emotional health in mainstream medicine.    

Oxford now sits at the forefront of mindfulness research and teaching internationally. Through the Oxford Mindfulness Centre (OMC) – established in 2008 within the Department of Psychiatry – researchers combine ancient wisdom with rigorous contemporary science to better understand the practice's potential for improving health and wellbeing.    

The centre's current research agenda has been developed in close collaboration with policy-makers, and the OMC is now undertaking major studies into the promise of mindfulness in education, the workplace and criminal justice systems. The establishment of a permanent post in mindfulness – the first of its kind globally – will enable Oxford to build a permanent research and training centre, and continue to be a leader in this field.    

Read more (Oxford Thinking website)

Similar stories

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

Experimental Medicine and Industry Partnership

The recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between a core team of Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institute, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.